financetom
Business
financetom
/
Business
/
Goldman Sachs, Morgan Stanley CEOs see more dealmaking in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs, Morgan Stanley CEOs see more dealmaking in 2025
Nov 3, 2024 2:02 PM

LONDON (Reuters) - The CEOs of Goldman Sachs ( GS ) and Morgan Stanley ( MS ) said on Tuesday they expected corporate dealmaking to pick up in 2025, while the CEO of Apollo Global Management ( APO ) said he expected a presidential victory by Donald Trump would spur more deals.

Ted Pick, CEO, Morgan Stanley ( MS ), told a panel debate at the Future Investment Initiative (FII) conference in Riyadh that the increase in activity would "be a global phenomenon", with bigger companies going public. Goldman boss David Solomon said on the same panel he also expected more robust activity next year.

Apollo Global Management ( APO ) CEO Marc Rowan said a Donald Trump victory in the upcoming U.S. presidential election would free up merger and acquisition activity and lead to investment liberalisation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Condor Energies Gives Update for Uzbekistan Gas Field Production Enhancement Project
Condor Energies Gives Update for Uzbekistan Gas Field Production Enhancement Project
Nov 3, 2024
08:49 AM EDT, 10/28/2024 (MT Newswires) -- Condor Energies ( CNPRF ) on Monday gave an operational update for its gas field production enhancement project in Uzbekistan. Two recently worked-over wells have returned to service and are providing 441 barrels of oil equivalent per day (boepd) of incremental production, the company said. As disclosed earlier this month, three prior workovers...
Biogen appoints insider as CFO after Michael McDonnell to retire next year
Biogen appoints insider as CFO after Michael McDonnell to retire next year
Nov 3, 2024
Oct 28 (Reuters) - Biogen said on Monday insider Robin Kramer would take over as its chief financial officer after Michael McDonnell plans to retire from the post in February 2025. McDonnell, who has been the finance chief since August 2020, played a pivotal role in the drugmaker's recent acquisitions and helped it to re-align its efforts to boost growth....
Biogen Finance Chief Michael McDonnell to Retire; Successor Named
Biogen Finance Chief Michael McDonnell to Retire; Successor Named
Nov 3, 2024
08:52 AM EDT, 10/28/2024 (MT Newswires) -- Biogen (BIIB) said Monday that Chief Financial Officer Michael McDonnell will retire on Feb. 28. McDonnell will be succeeded by Chief Accounting Officer Robin Kramer. Kramer, who joined Biogen in 2018, has been chief accounting officer since 2020. Prior to working at Biogen, Kramer held senior finance roles at Hertz Global ( HTZ...
AbbVie to buy Aliada Therapeutics for $1.4 billion
AbbVie to buy Aliada Therapeutics for $1.4 billion
Nov 3, 2024
Oct 28 (Reuters) - AbbVie ( ABBV ) said on Monday it would acquire therapy developer Aliada Therapeutics for $1.4 billion in cash. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved